Flow-Induced Constriction in Arterioles of Hyperhomocysteinemic Rats Is Due to Impaired Nitric Oxide and Enhanced Thromboxane A 2 Mediation

Publisher Website
Google Scholar
Abstract
—Hyperhomocysteinemia (HHcy) is thought to promote arteriosclerosis and peripheral arterial disease, in part by impairing the function of endothelium. Because flow-induced dilation is mediated by the endothelium, we hypothesized that HHcy alters this response by interfering with the synthesis/action of NO and prostaglandins. Thus, changes in the diameter of isolated, pressurized (at 80 mm Hg) gracilis skeletal muscle arterioles (diameter ≈170 μm) from control and methionine diet–induced HHcy rats were investigated with videomicroscopy. Increases in intraluminal flow (from 0 to 25 μL/min) resulted in dilations of control arterioles (maximum, 34±4 μm). In contrast, increases in flow elicited constrictions of HHcy arterioles (−36±3 μm). In control arterioles, the NO synthase inhibitor N ω -nitro- l -arginine-methyl ester significantly attenuated (≈50%) dilation, whereas the additional administration of indomethacin, an inhibitor of cyclooxygenase, eliminated flow-induced dilation. In the arterioles of HHcy rats, flow-induced constriction was not affected by N ω -nitro- l -arginine-methyl ester, whereas it was abolished by indomethacin or the prostaglandin H 2 /thromboxane A 2 (TXA 2 ) receptor antagonist SQ 29,548 or the TXA 2 synthase inhibitor CGS 13,080. Thus, in HHcy, increases in intraluminal flow elicit constrictions of skeletal muscle arterioles due to the impaired NO and enhanced TXA 2 mediation of the response, alterations that likely contribute to the development of peripheral arterial disease.

This publication has 19 references indexed in Scilit: